Dr. Stewart is eager to assist MBI as it seeks to expand its product pipeline and commercial offerings in the U.S. and global markets. "I'm thrilled to be joining MBI as they have always been on the forefront of innovation in bio-based pesticides. My duties to lead an already-successful program for in-licensing new technology, oversee the science for the development of new products from their internal discovery and manage a growing patent portfolio will give me the chance to leverage the exceptional science of MBI into a formidable competitive advantage in the marketplace." Dr. Stewart continues, "In addition, finding ways to advance our water technologies gives me the opportunity to apply my skills and knowledge to new industries and a whole new set of economically- and ecologically-important pest management challenges."About Marrone Bio InnovationsMarrone Bio Innovations, Inc. (MBI) is a leading global provider of bio-based management products for the agricultural and water treatment markets. Through its proprietary discovery and development platform and strategically in-licensed technologies, MBI has developed a pipeline of advanced and early-stage products for the significant agricultural and water treatment markets, including several nematicide, fungicide, algaecide and plant health product candidates. MBI's award-winning products include the biofungicide Regalia ® and Grandevo ®, a broad-spectrum bioinsecticide and Zequanox ®, the first natural product to selectively control invasive zebra and quagga mussels. MBI currently has more than 180 patents pending in the U.S. and globally. SOURCE Marrone Bio Innovations, Inc.